Viable Treatment Option for Age-related Macular Degeneration
Scientist announced that a component of the immune system inflammatory cytokine IL-18 can prevent, but does not cause, damage to blood vessels behind the retina at the back of eye. This new treatment could be replaceable option for wet AMD.